These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6240368)

  • 1. [Circadian variability of hydrosaluretic and antihypertensive effects of a single daily 25 mg. dose of chlorthalidone].
    Carpentiere G; Castello F; Marino S; Zarcone P; Castello A; Piovana U
    Clin Ter; 1984 Dec; 111(5):411-6. PubMed ID: 6240368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the antihypertensive effectiveness of low doses of chlorthalidone].
    De Giorgio LA; Innocenti F; Pettinà G; Seghieri G
    Clin Ter; 1982 Jun; 101(6):615-22. PubMed ID: 7128030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination].
    D'Amelio G; Dalla Volta S; De Longhi B; Razzolini R
    Minerva Med; 1974 May; 65(41):2342-9. PubMed ID: 4602117
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of chlorthalidone in mild hypertensives.
    Bagatin J; Pavlicević I; Sardelić S; Pivac N; Rumboldt Z
    Int J Clin Pharmacol Res; 1995; 15(5-6):201-8. PubMed ID: 8835618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo].
    Pasotti C; Rossi R; Gandolfi P
    Minerva Med; 1981 Nov; 72(46):3105-10. PubMed ID: 7029355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A; Tuomilehto J
    Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different blood pressure responses to diuretic treatment in normotensive subjects with and without a family history of hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Bianchetti MG
    J Hypertens Suppl; 1983 Dec; 1(2):31-4. PubMed ID: 6599492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chlorthalidone on peripheral resistance in the treatment of arterial hypertension].
    Oigman W; Ramirez JA; Sanjuliani AF; Fagundes VG; Talberg J; Bellotti G; Francischeti E; Pillegi F
    Arq Bras Cardiol; 1987 May; 48(5):323-6. PubMed ID: 3446129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with the antihypertensive agent Darebon].
    Iser H; Marburger P
    Med Welt; 1969 Jun; 26():1493-7. PubMed ID: 5801901
    [No Abstract]   [Full Text] [Related]  

  • 13. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F; Belogi M; Ansuini R; Campolucci G
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate.
    Bengtsson C; Johnsson G; Sannerstedt R; Werkö L
    Br Med J; 1975 Jan; 1(5951):197-9. PubMed ID: 1089446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.